These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Reversed changes of lipoxin A4 and leukotrienes in children with asthma in different severity degree. Wu SH; Yin PL; Zhang YM; Tao HX Pediatr Pulmonol; 2010 Apr; 45(4):333-40. PubMed ID: 20232472 [TBL] [Abstract][Full Text] [Related]
7. Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-onoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation. Clish CB; Levy BD; Chiang N; Tai HH; Serhan CN J Biol Chem; 2000 Aug; 275(33):25372-80. PubMed ID: 10837478 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of leukotriene B4 in neutrophils by lipoxins A4 and B4. Conti P; Reale M; Barbacane RC; Panara MR; Bongrazio M Agents Actions; 1991 Jan; 32(1-2):85-7. PubMed ID: 1647651 [TBL] [Abstract][Full Text] [Related]
13. Leukotriene B4 production in human mononuclear phagocytes is modulated by interleukin-4-induced 15-lipoxygenase. Profita M; Sala A; Siena L; Henson PM; Murphy RC; Paternò A; Bonanno A; Riccobono L; Mirabella A; Bonsignore G; Vignola AM J Pharmacol Exp Ther; 2002 Mar; 300(3):868-75. PubMed ID: 11861792 [TBL] [Abstract][Full Text] [Related]
14. Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1. Wan M; Godson C; Guiry PJ; Agerberth B; Haeggström JZ FASEB J; 2011 May; 25(5):1697-705. PubMed ID: 21307335 [TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton. Rao NL; Dunford PJ; Xue X; Jiang X; Lundeen KA; Coles F; Riley JP; Williams KN; Grice CA; Edwards JP; Karlsson L; Fourie AM J Pharmacol Exp Ther; 2007 Jun; 321(3):1154-60. PubMed ID: 17371808 [TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase- and lipoxygenase-derived eicosanoids in bronchoalveolar lavage fluid from patients with scleroderma lung disease: an imbalance between proinflammatory and antiinflammatory lipid mediators. Kowal-Bielecka O; Kowal K; Distler O; Rojewska J; Bodzenta-Lukaszyk A; Michel BA; Gay RE; Gay S; Sierakowski S Arthritis Rheum; 2005 Dec; 52(12):3783-91. PubMed ID: 16320329 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARgamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke. Sobrado M; Pereira MP; Ballesteros I; Hurtado O; Fernández-López D; Pradillo JM; Caso JR; Vivancos J; Nombela F; Serena J; Lizasoain I; Moro MA J Neurosci; 2009 Mar; 29(12):3875-84. PubMed ID: 19321784 [TBL] [Abstract][Full Text] [Related]
18. Lipoxins A4 and B4 inhibit leukotriene B4 generation from human neutrophil leukocyte suspensions. Conti P; Reale M; Barbacane RC; Bongrazio M; Panara MR Immunol Lett; 1990 Jul; 24(4):237-42. PubMed ID: 2167876 [TBL] [Abstract][Full Text] [Related]
19. A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. Gronert K; Maheshwari N; Khan N; Hassan IR; Dunn M; Laniado Schwartzman M J Biol Chem; 2005 Apr; 280(15):15267-78. PubMed ID: 15708862 [TBL] [Abstract][Full Text] [Related]
20. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes. József L; Zouki C; Petasis NA; Serhan CN; Filep JG Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13266-71. PubMed ID: 12235371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]